Inhibition of oncogenic kras-induced GM-CSF production and function
作者： Dafna Bar-Sagi , Yuliya Pylayeva-Gupta , Kyoung Eun Lee
DOI:
关键词: Tumor growth 、 Medicine 、 Pancreatic cancer 、 Function (biology) 、 Animal model 、 Biomedical engineering 、 Cancer research 、 GM-CSF production 、 Cancer 、 KRAS
摘要: The present invention is directed to methods of inhibiting tumor growth in a subject. further diagnosing cancer subject and identifying suitable course treatment for the based on diagnosis. also an orthotopic animal model pancreatic cancer.
lens.org参考文章(24)
Vincenzo Bronte, Anna Cabrelle, Nicholas P. Restifo, Dale B. Chappell, Elisa Apolloni, Patrick Hwu, Michael Wang, Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. Journal of Immunology. ,vol. 162, pp. 5728- 5737 ,(1999)
Khalid Zemzoumi, Paolo Renzi, Antisense oligonucleotides for treating allergy and neoplastic cell proliferation ,(2005)
Christine Plater-Zyberk, Inhibitors of gm-csf and il-17 for therapy ,(2009)
Philip M. Sass, Luigi Grasso, Eric Routhier, Nicholas C. Nicolaides, Qimin Chao, Wolfgang Ebel, Jian Li, Antigenic GM-CSF peptides and antibodies to GM-CSF ,(2007)
Elisabeth Thomassen-Wolf, Stefan Steidl, Anti-gm-csf antibodies and uses therefor ,(2006)
Barbara Mroczko, Maciej Szmitkowski, Urszula Wereszczyńska-Siemiątkowska, Grażyna Jurkowska, Hematopoietic cytokines in the sera of patients with pancreatic cancer. Clinical Chemistry and Laboratory Medicine. ,vol. 43, pp. 146- 150 ,(2005) , 10.1515/CCLM.2005.024
Thomas Condamine, Dmitry I. Gabrilovich, Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function Trends in Immunology. ,vol. 32, pp. 19- 25 ,(2011) , 10.1016/J.IT.2010.10.002
Johanna K. Morales, Maciej Kmieciak, Keith L. Knutson, Harry D. Bear, Masoud H. Manjili, GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Research and Treatment. ,vol. 123, pp. 39- 49 ,(2010) , 10.1007/S10549-009-0622-8
Jennifer S. Ko, Patricia Rayman, Joanna Ireland, Shadi Swaidani, Geqiang Li, Kevin D. Bunting, Brian Rini, James H. Finke, Peter A. Cohen, Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained Cancer Research. ,vol. 70, pp. 3526- 3536 ,(2010) , 10.1158/0008-5472.CAN-09-3278
Luigi Dolcetti, Elisa Peranzoni, Stefano Ugel, Ilaria Marigo, Audry Fernandez Gomez, Circe Mesa, Markus Geilich, Gregor Winkels, Elisabetta Traggiai, Anna Casati, Fabio Grassi, Vincenzo Bronte, Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF European Journal of Immunology. ,vol. 40, pp. 22- 35 ,(2009) , 10.1002/EJI.200939903